Skip to main content

23andme

By Jessica Hagen | 12:44 pm | July 01, 2025
The sale drew mixed reactions, with some U.S. states supporting it as a privacy measure and others objecting over legal and data concerns.
By Jessica Hagen | 12:51 pm | June 16, 2025
Wojcicki, cofounder and former CEO of 23andMe, is set to reacquire the company through her nonprofit, TTAM Research Institute.
By Anthony Vecchione | 01:04 pm | March 24, 2025
Following the announcement, California Attorney General Rob Bonta issued an urgent consumer alert advising users to request the company to delete their genetic data.   
By Emily Olsen | 02:33 pm | January 20, 2022
Also: Truepill launches a COVID-19 test coverage platform for insurers, and 23andMe extends its partnership with GSK.
By HIMSS TV | 08:40 am | October 14, 2019
Erin Trimble of 23andMe touches on the value of polygenic risk scores, how to use genetic information to improve health and the importance of equipping primary care providers to talk with their patients about genetics.

MobiHealthNews